Lumenis is one of the heavyweight names in aesthetic energy devices, so a new clearance from them — the MILAN System — is something your reps will bring up. That alone makes it worth thirty seconds of context.
The part that matters isn't the spec sheet; it's the sales motion. A premium-brand clearance usually arrives with trade-in offers, bundle pricing, and 'limited launch' urgency designed to get a high-ticket system onto your floor. None of that is bad — but it's a negotiation, not a verdict on fit.
Before the demo, get clear on what the MILAN is actually cleared to treat, how it overlaps with devices you already own, and what the per-treatment consumable cost does to your margins. A new platform only earns its lease if it opens a service you can't already deliver.
The cleared indication and applicant are in the FDA record.
View the official FDA record ↗
This post summarizes a public FDA database entry for medical-aesthetics owners. It is general business information, not medical, legal, or regulatory advice. Always confirm scope, lot numbers, and classification against the official FDA record, and consult your own clinician or counsel for anything clinical or compliance-related.